Circulating tumor DNA targeted sequencing reveals germline and somatic alterations that can guide decision making in metastatic castration-resistant prostate cancer

Circulating tumor DNA targeted sequencing reveals germline and somatic alterations that can guide decision making in metastatic castration-resistant prostate cancer

Bibliographic Details
Main Authors:	B. Dong, L. Fan, J. Pan, W. Xue
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320331724

Similar Items

Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations
by: Bonnet, I., et al.
Published: (2022)

Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration
by: Masayoshi Zaitsu, et al.
Published: (2012-01-01)

Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report
by: Yi Ma, et al.
Published: (2018-10-01)

Treatment sequencing in metastatic castrate-resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2014-06-01)

Germline and Somatic ALK Alterations in Neuroblastoma Patients
by: Ana Catarina Marinho da Rocha
Published: (2019)

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
by: Manish Kohli, et al.
Published: (2020-04-01)

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
by: Magbanua Mark, et al.
Published: (2012-02-01)

Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
by: Edoardo Francini, et al.
Published: (2021-08-01)

Germline variation controls the architecture of somatic alterations in tumors.
by: Amy M Dworkin, et al.
Published: (2010-09-01)

Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
by: Jeroen H. A. Creemers, et al.
Published: (2021-05-01)

Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
by: Gerit Theil, et al.
Published: (2021-07-01)

Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer
by: Anna S. Gerdtsson, et al.
Published: (2021-03-01)

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel
by: Ingeborg E. de Kruijff, et al.
Published: (2019-08-01)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Lixin Mai, et al.
Published: (2020-12-01)

Prognostic significance of time to castration resistance in patients with metastatic castration-sensitive prostate cancer
by: Y. Matsushita, et al.
Published: (2020-07-01)

Radium-223 in metastatic castration resistant prostate cancer
by: Winston Vuong, et al.
Published: (2014-06-01)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015-06-01)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer
by: Mostaghel EA
Published: (2014-01-01)

Haplotype-resolved germline and somatic alterations in renal medullary carcinomas
by: Kar-Tong Tan, et al.
Published: (2021-07-01)

Simultaneous detection of germline and somatic mutations in DNA repair genes by next generation sequencing of tumor samples from metastatic prostate cancer patients
by: Ariane Falconi
Published: (2021)

Sequencing of Cabazitaxel in Metastatic Castrate-Resistant Prostate Cancer: A Case Report
by: Donald Colbourn
Published: (2012-06-01)

Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer
by: Chun Wang, et al.
Published: (2021-01-01)

Interactions between Germline and Somatic Mutated Genes in Aggressive Prostate Cancer
by: Tarun Karthik Kumar Mamidi, et al.
Published: (2019-01-01)

Radium 223 in metastatic castration resistant prostate prostate. Effectiveness in clinical practice
by: M.C. Salas Buzón, et al.
Published: (2020-11-01)

Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians
by: Sanjoy Kumar Sureka, et al.
Published: (2016-01-01)

Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.
by: Núria Bonifaci, et al.
Published: (2010-11-01)

Characterizing glucocorticoid receptor in metastatic castration resistant prostate cancer
by: Kahn, Matthew Adam
Published: (2020)

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
by: Vincenza Conteduca, et al.
Published: (2021-01-01)

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
by: Dhruv Bansal, et al.
Published: (2021-01-01)

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
by: Joelle El-Amm, et al.
Published: (2013-08-01)

The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
by: Che-Kai Tsao, et al.
Published: (2014-06-01)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-03-01)

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
by: Joelle El-Amm, et al.
Published: (2013-01-01)

The changing landscape in the treatment of metastatic castration-resistant prostate cancer
by: Joelle El-Amm, et al.
Published: (2013-01-01)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-01-01)

Update on options for treatment of metastatic castration-resistant prostate cancer
by: Prakash Vishnu, et al.
Published: (2010-03-01)

Enzalutamide for patients with metastatic castration-resistant prostate cancer
by: Ramadan WH, et al.
Published: (2015-04-01)

Denosumab-induced hypocalcaemia in metastatic castrate-resistant prostate cancer
by: Florence Gunawan, et al.
Published: (2019-12-01)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
by: Cedric Pobel, et al.
Published: (2021-09-01)

An Ensemble Prognostic Model for Metastatic, Castrate-Resistant Prostate Cancer
by: Vang, Yeeleng Scott
Published: (2016)